Based on this evidence, Wijnen et al. investigated the association between the presence of the TNF-α G 308A polymorphism and response to TNF-α inhibitors (adalimumab or infliximab) in 111 patients with refractory sarcoidosis. This evidence concerns the gene TNF and sarcoidosis.